Recombinant multi-species CIDEC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CIDEC protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a member of the cell death-inducing DNA fragmentation factor-like effector family. Members of this family play important roles in apoptosis. The encoded protein promotes lipid droplet formation in adipocytes and may mediate adipocyte apoptosis. This gene is regulated by insulin and its expression is positively correlated with insulin sensitivity. Mutations in this gene may contribute to insulin resistant diabetes. A pseudogene of this gene is located on the short arm of chromosome 3. Alternatively spliced transcript variants that encode different isoforms have been observed for this gene. [provided by RefSeq, Dec 2010]
The Alternative Names of target: CIDE-3,CIDE3,CIDEC,Cell death activator CIDE-3,Cell death-inducing DFFA-like effector protein C,Cidec,FPLD5,FSP27,Fat-specific protein FSP27 homolog,Fsp27,Lipid transferase CIDEC

Target products collectionGo to CIDEC products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP11068-Ag-1/ GM-Tg-hg-IP11068-Ag-2 Human CIDEC protein Human
GM-Tg-rg-IP11068-Ag-1/ GM-Tg-rg-IP11068-Ag-2 Rat CIDEC protein Rat
GM-Tg-mg-IP11068-Ag-1/ GM-Tg-mg-IP11068-Ag-2 Mouse CIDEC protein Mouse
GM-Tg-cynog-IP11068-Ag-1/ GM-Tg-cynog-IP11068-Ag-2 Cynomolgus/Rhesus macaque CIDEC protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP11068-Ag-1/ GM-Tg-felg-IP11068-Ag-2 Feline CIDEC protein Feline
GM-Tg-cang-IP11068-Ag-1/ GM-Tg-cang-IP11068-Ag-2 Canine CIDEC protein Canine
GM-Tg-bovg-IP11068-Ag-1/ GM-Tg-bovg-IP11068-Ag-2 Bovine CIDEC protein Bovine
GM-Tg-equg-IP11068-Ag-1/ GM-Tg-equg-IP11068-Ag-2 Equine CIDEC protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP11068-Ag-1/ GM-Tg-hg-IP11068-Ag-2; GM-Tg-rg-IP11068-Ag-1/ GM-Tg-rg-IP11068-Ag-2;
GM-Tg-mg-IP11068-Ag-1/ GM-Tg-mg-IP11068-Ag-2; GM-Tg-cynog-IP11068-Ag-1/ GM-Tg-cynog-IP11068-Ag-2;
GM-Tg-felg-IP11068-Ag-1/ GM-Tg-felg-IP11068-Ag-2; GM-Tg-cang-IP11068-Ag-1/ GM-Tg-cang-IP11068-Ag-2;
GM-Tg-bovg-IP11068-Ag-1/ GM-Tg-bovg-IP11068-Ag-2; GM-Tg-equg-IP11068-Ag-1/ GM-Tg-equg-IP11068-Ag-2
Products Name CIDEC protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name CIDEC
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine CIDEC protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.